产品中心Cell Resources
联系我们CONTACT US
- 400-999-210024小时服务热线
产品概述
名称 | PC-9 (人肺癌细胞) (STR鉴定正确) |
别称 | PC9; PC-9/S1; PC-9S1 |
种属 | 人 |
生长特性 | 贴壁细胞,少量悬浮 |
细胞形态 | 圆形和纺锤形混合 |
冻存条件 | 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮 |
培养方案A(默认) |
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
|
推荐传代比例 | 1:3-1:5 |
推荐换液频率 | 2-3次/周 |
背景描述 | 源自人肺腺癌,该肺组织仍处于分化状态。PC-9(以前称为PC-14)。PC-14 最初于1989 年作为源自人肺腺癌(未分化型)的细胞系存放在RIKEN生物资源中心。该生物资源中心通过短串联重复序列 (STR) DNA 分析发现该细胞系与 PC-9 相同,PC-9 是源自人肺腺癌(分化型)的细胞系。此错误识别发生在细胞系存放在 RIKEN 生物资源中心之前。细胞系的名称更改为 PC-9,以反映这一发现。 |
年龄(性别) | 男性;45岁 |
组织来源 | 肺 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 肺癌细胞 |
生物安全等级 | BSL-1 |
倍增时间 | ~48 hours |
STR鉴定
-
STR位点信息
Amelogenin X CSF1PO 11 D2S1338 19,20 D3S1358 16 D5S818 11 D7S820 10,11 D8S1179 11,15 D13S317 8 D16S539 9 D18S51 15 D19S433 13,15.2 D21S11 29,30 FGA 23 PentaD 9,13 PentaE 11,15 TH01 7 TPOX 11 vWA 17 D6S1043 13,19 D12S391 18 D2S441 11 -
STR鉴定图
参考文献
-
circNOX4 activates an inflammatory fibroblast niche to promote tumor growth and metastasis in NSCLC via FAP/IL-6 axis (2024-03-08)
作者:Yan Zhao:1.Department of Tumor Immunotherapy, The Fourth Hospital of Hebei Medical University and Hebei Provincial Tumor Hospital, Shijiazhuang, 050035, China. ; 2.Department of Oncology, The Fourth Hospital of Hebei Medical University and Hebei Provincial Tumor Hospital, Shijiazhuang, 050011, China. ; Yunlong Jia:1.Department of Tumor Immunotherapy, The Fourth Hospital of Hebei Medical University and Hebei Provincial Tumor Hospital, Shijiazhuang, 050035, China. ; Jiali Wang:1.Department of Tumor Immunotherapy, The Fourth Hospital of Hebei Medical University and Hebei Provincial Tumor Hospital, Shijiazhuang, 050035, China. ; Xiaolin Chen:1.Department of Nuclear Medicine, The Fourth Hospital of Hebei Medical University and Hebei Provincial Tumor Hospital, Shijiazhuang, 050011, China. ; Jingya Han:1.Department of Nuclear Medicine, The Fourth Hospital of Hebei Medical University and Hebei Provincial Tumor Hospital, Shijiazhuang, 050011, China. ; Shuman Zhen:1.Department of Tumor Immu
期刊:circNOX4 activates an inflammatory fibroblast niche to promote tumor growth and metastasis in NSCLC via FAP/IL-6 axis
DOI:10.1186/s12943-024-01957-5
影响因子 :37.3
引用产品: A549 [A-549] 细胞 , PC-9 细胞 , NCI-H226 [H226] 细胞 , H1581 细胞 , BEAS-2B 细胞
-
NEAT1_1 confers gefitinib resistance in lung adenocarcinoma through promoting AKR1C1-mediated ferroptosis defence (2024-03-12)
作者:Shuman Zhen:1.Department of Tumor Immunotherapy, Fourth Hospital of Hebei Medical University, Shijiazhuang, 050035, China. ; 2.China International Cooperation Laboratory of Stem Cell Research, Institute of Medical and Health Science of Hebei Medical University, Shijiazhuang, 050017, China. ; 3.Department of Radiotherapy, Fourth Hospital of Hebei Medical University, Shijiazhuang, 050017, China. ; Yunlong Jia:1.Department of Tumor Immunotherapy, Fourth Hospital of Hebei Medical University, Shijiazhuang, 050035, China. ; 2.China International Cooperation Laboratory of Stem Cell Research, Institute of Medical and Health Science of Hebei Medical University, Shijiazhuang, 050017, China. ; Yan Zhao:1.Department of Tumor Immunotherapy, Fourth Hospital of Hebei Medical University, Shijiazhuang, 050035, China. ; 2.China International Cooperation Laboratory of Stem Cell Research, Institute of Medical and Health Science of Hebei Medical University, Shijiazhuang, 050017, China. ; 3.Department of
期刊:NEAT1_1 confers gefitinib resistance in lung adenocarcinoma through promoting AKR1C1-mediated ferroptosis defence
DOI:10.1038/s41420-024-01892-w
影响因子 :7.0
-
Identification of key immune cells infiltrated in lung adenocarcinoma microenvironment and their related long noncoding RNA (2024-02-15)
作者:Kai Wang:1.Institute of Oncology, Shandong Provincial Hospital, Shandong University, Jinan, China. ; 2.Department of Healthcare Respiratory Medicine, Shandong Provincial Hospital, Shandong University, Jinan, China. ; Tao Yan:1.Lung Transplantation Center, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi 214023, China. ; Deyu Guo:1.Institute of Oncology, Shandong Provincial Hospital, Shandong University, Jinan, China. ; Shijie Sun:1.Institute of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China. ; Yong Liu:1.Institute of Oncology, Shandong Provincial Hospital, Shandong University, Jinan, China. ; Qiang Liu:1.Institute of Oncology, Shandong Provincial Hospital, Shandong University, Jinan, China. ; Guanghui Wang:1.Institute of Oncology, Shandong Provincial Hospital, Shandong University, Jinan, China. ; 2.Department of Thoracic Surgery,
期刊:Identification of key immune cells infiltrated in lung adenocarcinoma microenvironment and their related long noncoding RNA
DOI:10.1016/j.isci.2024.109220
影响因子 :5.8
引用产品: PC-9 细胞 , A549 [A-549] 细胞
-
Macrophage-Related Gene Signatures for Predicting Prognosis and Immunotherapy of Lung Adenocarcinoma by Machine Learning and Bioinformatics (2024-02-06)
作者:Yunzhi Xiang:1.Institute of Oncology, Shandong Provincial Hospital, Shandong University, Jinan, People's Republic of China. ; Guanghui Wang:1.Institute of Oncology, Shandong Provincial Hospital, Shandong University, Jinan, People's Republic of China. ; Baoliang Liu:1.Institute of Oncology, Shandong Provincial Hospital, Shandong University, Jinan, People's Republic of China. ; Haotian Zheng:1.Institute of Oncology, Shandong Provincial Hospital, Shandong University, Jinan, People's Republic of China. ; Qiang Liu:1.Institute of Oncology, Shandong Provincial Hospital, Shandong University, Jinan, People's Republic of China. ; Guoyuan Ma:1.Institute of Oncology, Shandong Provincial Hospital, Shandong University, Jinan, People's Republic of China. ; Jiajun Du:1.Institute of Oncology, Shandong Provincial Hospital, Shandong University, Jinan, People's Republic of China. ;
期刊:Macrophage-Related Gene Signatures for Predicting Prognosis and Immunotherapy of Lung Adenocarcinoma by Machine Learning and Bioinformatics
影响因子 :4.5
引用产品: A549 [A-549] 细胞 , PC-9 细胞
-
Design, synthesis and biological evaluation of rhein–piperazine–furanone hybrids as potential anticancer agents (2024-02-13)
作者:Yu He:1.State Key Laboratory of High-efficiency Utilization of Coal and Green Chemical Engineering, Ningxia Research Center for Natural Medicine Engineering and Technology, College of Chemistry and Chemical Engineering, Ningxia University 489 Helanshan West Road Yinchuan 750021 China weimengxue@nxu.edu.cn. ; Si-Si Zhang:1.State Key Laboratory of High-efficiency Utilization of Coal and Green Chemical Engineering, Ningxia Research Center for Natural Medicine Engineering and Technology, College of Chemistry and Chemical Engineering, Ningxia University 489 Helanshan West Road Yinchuan 750021 China weimengxue@nxu.edu.cn. ; Meng-Xue Wei:1.State Key Laboratory of High-efficiency Utilization of Coal and Green Chemical Engineering, Ningxia Research Center for Natural Medicine Engineering and Technology, College of Chemistry and Chemical Engineering, Ningxia University 489 Helanshan West Road Yinchuan 750021 China weimengxue@nxu.edu.cn. ;
期刊:Design, synthesis and biological evaluation of rhein–piperazine–furanone hybrids as potential anticancer agents
影响因子 :4.1
引用产品: A549 [A-549] 细胞 , NCI-H460 [H460] 细胞 , PC-9 细胞 , Calu-1 细胞 , SK-BR-3 [SKBR3] 细胞 , SK-OV-3 细胞 , 786-O [786-0] 细胞 , HuH-7 细胞 , HCT 116 细胞 , Hela 细胞 , WI-38 细胞 , MCF 10A 细胞 , KGN 细胞 , 293T [HEK-293T] 细胞 , DMEM高糖 培养基 , MEM 培养基 , DMEM/F12 培养基 , McCoy's 5A 培养基 , RPMI-1640 培养基 , 0.25%胰蛋白酶溶液 (含EDTA,溶于PBS)
-
Silencing of circ_0088036 inhibits growth and invasion of lung adenocarcinoma through miR-203/SP1 axis (2024-03-27)
作者:Xiuhua Liu:1.Department of Respiratory Medicine, The First Hospital of Jilin University, Changchun, Jilin, China. ; Yan Feng:1.Department of Oncology, General Hospital of Heilongjiang Province Land Reclamation Bureau, Harbin, Heilongjiang, China. ; Linna Wang:1.Department of Oncology, General Hospital of Heilongjiang Province Land Reclamation Bureau, Harbin, Heilongjiang, China. ; Lei Shi:1.Department of Oncology, General Hospital of Heilongjiang Province Land Reclamation Bureau, Harbin, Heilongjiang, China. ; Kunxiang Ji:1.Department of Oncology, General Hospital of Heilongjiang Province Land Reclamation Bureau, Harbin, Heilongjiang, China. ; Nan Hu:1.Department of Oncology, General Hospital of Heilongjiang Province Land Reclamation Bureau, Harbin, Heilongjiang, China. ; Yang Du:1.Department of Oncology, General Hospital of Heilongjiang Province Land Reclamation Bureau, Harbin, Heilongjiang, China. ; Mingyang Liu:1.Department of Oncology, General Hospital of Heilongjiang Provin
期刊:Silencing of circ_0088036 inhibits growth and invasion of lung adenocarcinoma through miR-203/SP1 axis
影响因子 :3.6
引用产品: A549 [A-549] 细胞 , NCI-H1299 细胞 , PC-9 细胞 , NCI-H1975 细胞 , BEAS-2B 细胞
-
KIAA1429-mediated RXFP1 attenuates non-small cell lung cancer tumorigenesis via N6-methyladenosine modification (2024-02-07)
作者:Zhixiang Zhang:1.Department of Medical Laboratory, Wuhan Third Hospital, Wuhan, Hubei, China. ; 2.Department of Medical Laboratory, Wuhan Third Hospital, Wuhan, Hubei, China. ; Jipeng Guo:1.Department of Oncology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. ; 2.Department of Medical Laboratory, Wuhan Third Hospital, Wuhan, Hubei, China. ; Chongwen Gong:1.Department of Oncology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. ; 2.Department of Medical Laboratory, Wuhan Third Hospital, Wuhan, Hubei, China. ; Sai Wu:1.Department of Thoracic Surgery, Wuhan Third Hospital, Wuhan, Hubei, China. ; Yanlei Sun:1.Department of Endocrinology, Wuhan Third Hospital, Wuhan, Hubei, China. ;
期刊:KIAA1429-mediated RXFP1 attenuates non-small cell lung cancer tumorigenesis via N6-methyladenosine modification
影响因子 :3.1
引用产品: BEAS-2B 细胞 , HCC827 细胞 , PC-9 细胞 , RPMI-1640 培养基 , DMEM高糖 培养基 , 特级胎牛血清
-
ORC6 acts as an effective prognostic predictor for non‑small cell lung cancer and is closely associated with tumor progression (2024-01-11)
作者:Letian Chen:1.Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330000, P.R. China. ; Dongdong Zhang:1.Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330000, P.R. China. ; Yujuan Chen:1.Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330000, P.R. China. ; Huilan Zhu:1.Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330000, P.R. China. ; Zhipeng Liu:1.Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330000, P.R. China. ; Zhiping Yu:1.Department of Pulmonary and Critical Care Medicine, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330000, P.R. China. ; Junping Xie:1.Department of Pulmonary and Critic
期刊:ORC6 acts as an effective prognostic predictor for non‑small cell lung cancer and is closely associated with tumor progression
影响因子 :2.9
引用产品: A549 [A-549] 细胞 , PC-9 细胞 , NCI-H1299 细胞 , NCI-H1650 细胞 , BEAS-2B 细胞
-
The m6 RNA methylation regulator KIAA1429 is associated with autophagy‐mediated drug resistance in lung cancer (2024-03-15)
作者:Bo Ma:1.Department of General Thoracic Surgery General Hospital of Ningxia Medical University Yinchuan China. ; Lei Xiu:1.Department of Thoracic and Cardiac Surgery General Hospital of Ningxia Medical University Yinchuan China. ; Lili Ding:1.Department of Obstetrics and Gynecology Examination General Hospital of Ningxia Medical University Yinchuan China. ;
期刊:The m6 RNA methylation regulator KIAA1429 is associated with autophagy‐mediated drug resistance in lung cancer
影响因子 :2.7
-
Integrin β4 Regulates Cell Migration of Lung Adenocarcinoma Through FAK Signaling (2024-02-08)
作者:Shusen Zhang:1.Hebei Province Xingtai People's Hospital Postdoctoral Workstation, Xingtai, China. ; 2.Postdoctoral Mobile Station, Hebei Medical University, Shijiazhuang, China. ; 3.Department of Pulmonary and Critical Care Medicine, Affiliated Xing Tai People Hospital of Hebei Medical University, Xingtai, China. ; 4.The First Department of Pulmonary and Critical Care Medicine, The Second Hospital of Hebei Medical University, Shijiazhuang, China. ; Chengyu Liu:1.Department of Surgery, Graduate School of Hebei Medical University, Shijiazhuang, China. ; Dengxiang Liu:1.Department of Oncology, Affiliated Xing Tai People Hospital of Hebei Medical University, Xingtai, China. ; Xuecong Ning:1.Department of Pulmonary and Critical Care Medicine, Affiliated Xing Tai People Hospital of Hebei Medical University, Xingtai, China. ; Hui Li:1.Department of Oncology, Affiliated Xing Tai People Hospital of Hebei Medical University, Xingtai, China. ; Xiaochong Zhang:1.Department of Oncology, Affili
期刊:Integrin β4 Regulates Cell Migration of Lung Adenocarcinoma Through FAK Signaling
DOI:10.1007/s12033-024-01061-5
影响因子 :2.6
引用产品: A549 [A-549] 细胞 , PC-9 细胞
-
NFATc2 promotes lactate and M2 macrophage polarization through USP17 in lung adenocarcinoma (2024-02-23)
作者:Liang Wang:1.Department of Thoracic Surgery II, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing. ; Yuanyuan Ma:1.Department of Thoracic Surgery II, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing. ; Shanyuan Zhang:1.Department of Thoracic Surgery II, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing. ; Yue Yang:1.Department of Thoracic Surgery II, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing. ; Bo Huang:1.Departments of Thoracic Surgery, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China. ;
期刊:NFATc2 promotes lactate and M2 macrophage polarization through USP17 in lung adenocarcinoma
DOI:10.1097/CAD.0000000000001582
影响因子 :2.3
引用产品: PC-9 细胞
-
Synergistic anti-tumor effects of lenalidomide and gefitinib by upregulating ADRB2 and inactivating the mTOR/PI3K/AKT signaling pathway in lung adenocarcinoma (2024-02-29)
作者:Shuangshuang Zhou:1.Department of Oncology, Dushu Lake Hospital Affiliated to Soochow University, Suzhou, Jiangsu Province, 215123, China. sszhouss@stu.suda.edu.cn. ; Meiyi Deng:1.Department of Oncology, Dushu Lake Hospital Affiliated to Soochow University, Suzhou, Jiangsu Province, 215123, China. 20214256009@stu.suda.edu.cn. ; Xuyu Bian:1.Department of Oncology, Dushu Lake Hospital Affiliated to Soochow University, Suzhou, Jiangsu Province, 215123, China. bianxuyu_edu@outlook.com. ; Jindong Shi:1.Department of Pulmonary and Critical Care Medicine, Shanghai Fifth People's Hospital, Fudan University, Shanghai, 200240, China. shijindong@fudan.edu.cn. ; Rongrui Liang:1.Department of Oncology, Dushu Lake Hospital Affiliated to Soochow University, Suzhou, Jiangsu Province, 215123, China. lengbeng@suda.edu.cn. ; Min Tao:1.Department of Oncology, Dushu Lake Hospital Affiliated to Soochow University, Suzhou, Jiangsu Province, 215123, China. taomin@suda.edu.cn. ;
期刊:Synergistic anti-tumor effects of lenalidomide and gefitinib by upregulating ADRB2 and inactivating the mTOR/PI3K/AKT signaling pathway in lung adenocarcinoma
影响因子 :1.6
引用产品: NCI-H460 [H460] 细胞 , PC-9 细胞
-
Original research: Hsa-LINC02418/mmu-4930573I07Rik regulated by METTL3 dictates anti-PD-L1 immunotherapeutic efficacy via enhancement of Trim21-mediated PD-L1 ubiquitination (2023-12-01)
作者:Zhijia Sun:1.Department of Genetic Engineering, Beijing Institute of Biotechnology, Beijing, China. ; 2.Department of Radiation Oncology, Air Force Medical Center PLA, Air Force Medical University, Beijing, China. ; Haixing Mai:1.Department of Urology, the Third Medical Center of PLA General Hospital, Beijing, China. ; Chunyuan Xue:1.Department of Genetic Engineering, Beijing Institute of Biotechnology, Beijing, China. ; Zhongyi Fan:1.Department of Biotherapy Center, Third People's Hospital, Second Hospital Affiliated to Southern University of Science and Technology, Shenzhen, Guangdong, China. ; Jiangbo Li:1.Bioinformatics Center of Academy of Military Medical Sciences, Beijing, China. ; Hairui Chen:1.Department of Urology, the Third Medical Center of PLA General Hospital, Beijing, China. ; Nan Huo:1.Department of Genetic Engineering, Beijing Institute of Biotechnology, Beijing, China. ; Xiaofeng Kang:1.Department of Genetic Engineering, Beijing Institute of Biotechnology, Beij
期刊:Original research: Hsa-LINC02418/mmu-4930573I07Rik regulated by METTL3 dictates anti-PD-L1 immunotherapeutic efficacy via enhancement of Trim21-mediated PD-L1 ubiquitination
影响因子 :10.9
引用产品: PC-9 细胞
-
Disulfiram enhances cisplatin cytotoxicity by forming a novel platinum chelate Pt(DDTC)3+ (2023-03-11)
作者:Xue-Xia Yuan:1.State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China; Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China. ; You-Fa Duan:1.State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China; Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou 510080, China. ; Chunxiang Luo:1.School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China. ; Lu Li:1.State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, China. ; Meng-Jie Yang:1.School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen 518107, Guangdong, China. ; Ting-Yu Liu:1.State Key Laboratory of Oncology in South China, Collaborati
期刊:Disulfiram enhances cisplatin cytotoxicity by forming a novel platinum chelate Pt(DDTC)3+
影响因子 :5.8
-
Onvansertib inhibits the proliferation and improves the cisplatin-resistance of lung adenocarcinoma via β-catenin/c-Myc signaling pathway (2023-02-15)
作者:Rong Wang:1.Medical College, Guangxi University Nanning, Guangxi, P.R. China. ; Yihan Hou:1.Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University, School of Clinical Medicine, Xiamen University Xiamen 361003, Fujian Province, P.R. China. ; Guojun Geng:1.Department of Thoracic Surgery, Xiamen Key Laboratory of Thoracic Tumor Diagnosis and Treatment, Institute of Lung Cancer, The First Affiliated Hospital of Xiamen University, School of Clinical Medicine, Xiamen University Xiamen 361003, Fujian Province, P.R. China. ; Xiaolei Zhu:1.Department of Thoracic Surgery, Xiamen Key Laboratory of Thoracic Tumor Diagnosis and Treatment, Institute of Lung Cancer, The First Affiliated Hospital of Xiamen University, School of Clinical Medicine, Xiamen University Xiamen 361003, Fujian Province, P.R. China. ; Zhilin Wang:1.Department of Thoracic Surgery, Xiamen Key Laboratory of Thoracic Tumor Diagnosis an
期刊:Onvansertib inhibits the proliferation and improves the cisplatin-resistance of lung adenocarcinoma via β-catenin/c-Myc signaling pathway
DOI:PMID:36895968
影响因子 :5.3
引用产品: A549 [A-549] 细胞 , PC-9 细胞
-
Targeting PKD2 aggravates ferritinophagy-mediated ferroptosis via promoting autophagosome-lysosome fusion and enhances efficacy of carboplatin in lung adenocarcinoma (2023-11-10)
作者:Yong Liu:1.Institute of Oncology, Shandong Provincial Hospital, Shandong University, Jinan, 250021, Shandong, China. ; Zhaofei Pang:1.Institute of Oncology, Shandong Provincial Hospital, Shandong University, Jinan, 250021, Shandong, China; Institute of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China; Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China. ; Yadong Wang:1.Institute of Oncology, Shandong Provincial Hospital, Shandong University, Jinan, 250021, Shandong, China. ; Jichang Liu:1.Institute of Oncology, Shandong Provincial Hospital, Shandong University, Jinan, 250021, Shandong, China. ; Guanghui Wang:1.Institute of Oncology, Shandong Provincial Hospital, Shandong University, Jinan, 250021, Shandong, China; Institute of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shand
期刊:Targeting PKD2 aggravates ferritinophagy-mediated ferroptosis via promoting autophagosome-lysosome fusion and enhances efficacy of carboplatin in lung adenocarcinoma
影响因子 :5.1
引用产品: A549 [A-549] 细胞 , PC-9 细胞 , 293 [HEK-293] 细胞
-
Comprehensive analysis of cuproptosis and copper homeostasis genotyping and related immune land scape in lung adenocarcinoma (2023-10-02)
作者:Dayuan Luo:1.Department of Thoracic Surgery, Second Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China. ; Xiang Wang:1.Department of Thoracic Surgery, Second Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China. ; Wei Feng:1.Department of Cardiothoracic Surgery, Third Xiangya Hospital, Central South University, Changsha, 410013, Hunan, China. fweimail@163.com. ;
期刊:Comprehensive analysis of cuproptosis and copper homeostasis genotyping and related immune land scape in lung adenocarcinoma
DOI:10.1038/s41598-023-43795-3
影响因子 :4.6
引用产品: PC-9 细胞 , NCI-H1975 细胞 , 16HBE 细胞 , 特级胎牛血清
-
Development and validation of an endoplasmic reticulum stress long non-coding RNA signature for the prognosis and immune landscape prediction of patients with lung adenocarcinoma (2023-02-20)
作者:Jie Zeng:1.Department of Thoracic Surgery, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, China. ; Zhenyu Wu:1.Department of Urology, The First People's Hospital of Foshan, Foshan, China. ; Meijuan Luo:1.Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China. ; 2.Department of Radiology, Sun Yat-sen University Cancer Center, Guangzhou, China. ; Xie Xu:1.Department of Thoracic Surgery, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, China. ; Wenjie Bai:1.Department of Thoracic Surgery, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, China. ; Guijing Xie:1.Department of Thoracic Surgery, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, China. ; Quhai Chen:1.Department of Thoracic Surgery, Guangzhou First People's Hospital, South China Unive
期刊:Development and validation of an endoplasmic reticulum stress long non-coding RNA signature for the prognosis and immune landscape prediction of patients with lung adenocarcinoma
DOI:10.3389/fgene.2023.1024444
影响因子 :3.7
引用产品: A549 [A-549] 细胞 , PC-9 细胞 , SK-LU-1 细胞 , 16HBE 细胞
-
Multi-omics analysis of expression profile and prognostic values of connexin family in LUAD (2023-07-17)
作者:Peng Jiang:1.Precision Medicine Center of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, 266071, China. ; 2.Qingdao University, Qingdao, 266071, China. ; Xingfa Huo:1.Qingdao University, Qingdao, 266071, China. ; Bowen Dong:1.Qingdao University, Qingdao, 266071, China. ; Na Zhou:1.Precision Medicine Center of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, 266071, China. zhouna@qdu.edu.cn. ; Xiaochun Zhang:1.Precision Medicine Center of Oncology, The Affiliated Hospital of Qingdao University, Qingdao, 266071, China. zxc9670@qdu.edu.cn. ;
期刊:Multi-omics analysis of expression profile and prognostic values of connexin family in LUAD
DOI:10.1007/s00432-023-05075-5
影响因子 :3.6
引用产品: NCI-H1975 细胞 , HCC827 细胞 , A549 [A-549] 细胞 , PC-9 细胞 , BEAS-2B 细胞
-
CircDUS2L (circ_0039908) promotes lung adenocarcinoma progression by upregulating PGAM1 by acting as a miR-590-5p molecular sponge (2023-07-01)
作者:Qing Tian:1.Department of Thoracic surgery, The First Hospital of Hebei Medical University, Shijiazhuang City, Hebei Province, China. ; Ying Guo:1.Department of Oncology, The First Hospital of Hebei Medical University, Shijiazhuang City, Hebei Province, China. ; Jinfeng Liu:1.Department of Thoracic surgery, The First Hospital of Hebei Medical University, Shijiazhuang City, Hebei Province, China. ; Chao Pang:1.Department of Pathology, The First Hospital of Hebei Medical University, Shijiazhuang City, Hebei Province, China. ; Qiang Wang:1.Department of Thoracic surgery, The First Hospital of Hebei Medical University, Shijiazhuang City, Hebei Province, China. ; Qi Xie:1.Department of Clinical Nutrition, The Fourth Hospital of Hebei Medical University, Shijiazhuang City, Hebei Province, China. ; Jianke Li:1.Department of Thoracic surgery, The First Hospital of Hebei Medical University, Shijiazhuang City, Hebei Province, China. ;
期刊:CircDUS2L (circ_0039908) promotes lung adenocarcinoma progression by upregulating PGAM1 by acting as a miR-590-5p molecular sponge
影响因子 :3.6
引用产品: 293T [HEK-293T] 细胞 , BEAS-2B 细胞 , A549 [A-549] 细胞 , PC-9 细胞 , DMEM高糖 培养基 , Ham's F-12K 培养基 , RPMI-1640 培养基 , 青霉素-链霉素溶液 (双抗),100×
-
STARD12/14 are diagnostic and prognostic biomarkers of lung adenocarcinoma associated with epigenetic regulation, immune infiltration and ferroptosis (2023-09-11)
作者:Wen-Di Zhang:1.Department of Pulmonary and Critical Care Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Shandong Key Laboratory of infectious respiratory diseases, Jinan, China. ; Dong-Mei Hu:1.Department of Pulmonary and Critical Care Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Shandong Key Laboratory of infectious respiratory diseases, Jinan, China. ; Zhuang-E Shi:1.Department of Pulmonary and Critical Care Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Shandong Key Laboratory of infectious respiratory diseases, Jinan, China. ; Qing-Xiang Wang:1.Department of Pulmonary and Critical Care Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Shandong Key Laboratory of infectious respiratory diseases, Jinan, China. ; Meng-Yu Zhang:1.Department of Pulmonary and Critical Care Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Shandong Key Laboratory of in
期刊:STARD12/14 are diagnostic and prognostic biomarkers of lung adenocarcinoma associated with epigenetic regulation, immune infiltration and ferroptosis
影响因子 :3.6
引用产品: BEAS-2B 细胞 , NCI-H1299 细胞 , A549 [A-549] 细胞 , PC-9 细胞
-
Development of the prognostic value in lung adenocarcinoma based on anoikis-related genes and initial experimental validation (2023-05-31)
作者:Wenwei Guo:1.Department of Thoracic Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. ; 2.Department of Cardiothoracic Surgery, Ji 'an Central People's Hospital, Ji'an, China. ; Guang Zhao:1.Department of Thoracic Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. ; Suping Liu:1.Department of Rehabilitation Medicine, Ji'an Central People's Hospital, Ji'an, China. ; Tao Deng:1.Department of Pain, Ji 'an Central People's Hospital, Ji'an, China. ; Guangjian Zhang:1.Department of Thoracic Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. ; Boxiang Zhang:1.Department of Thoracic Surgery, the First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. ;
期刊:Development of the prognostic value in lung adenocarcinoma based on anoikis-related genes and initial experimental validation
DOI:10.1002/jgm.3534
影响因子 :3.5
引用产品: BEAS-2B 细胞 , PC-9 细胞 , A549 [A-549] 细胞
-
Evaluation of hsa_circ_0000018/let-7f-5p/ FAM96A axis in lung adenocarcinoma progression (2023-11-23)
作者:Qi Li:1.Pulmonary and Critical Care Medicine, Affiliated Puren Hospital of Wuhan University of Science and Technology, Wuhan, Hubei, China. ; Min Zhao:1.Pulmonary and Critical Care Medicine, Affiliated Puren Hospital of Wuhan University of Science and Technology, Wuhan, Hubei, China. ; Dan-Dan Hu:1.Pulmonary and Critical Care Medicine, Affiliated Puren Hospital of Wuhan University of Science and Technology, Wuhan, Hubei, China. ; Jun-Jiao Qin:1.Pulmonary and Critical Care Medicine, Affiliated Puren Hospital of Wuhan University of Science and Technology, Wuhan, Hubei, China. ; Wei He:1.Department of Oncology, Affiliated Puren Hospital of Wuhan University of Science and Technology, Wuhan, Hubei, China. ;
期刊:Evaluation of hsa_circ_0000018/let-7f-5p/ FAM96A axis in lung adenocarcinoma progression
影响因子 :3.1
引用产品: BEAS-2B 细胞 , A549 [A-549] 细胞 , PC-9 细胞 , DMEM高糖 培养基 , Ham's F-12K 培养基 , RPMI-1640 培养基 , 特级胎牛血清
-
Circ_0043256 upregulates KLF2 expression by absorbing miR-1206 to suppress the tumorigenesis of lung cancer (2023-01-21)
作者:Ying Zhou:1.Department of Respiratory and Critical Care Medicine, Jingmen No.1 People's Hospital, Jingmen, China. ; Hongliu Liu:1.Department of Oncology, Jingmen No.1 People's Hospital, Jingmen, China. ; Rui Wang:1.Department of Oncology, Jingmen No.1 People's Hospital, Jingmen, China. ; Mingtao Zhang:1.Department of Oncology, Jingmen No.1 People's Hospital, Jingmen, China. ;
期刊:Circ_0043256 upregulates KLF2 expression by absorbing miR-1206 to suppress the tumorigenesis of lung cancer
影响因子 :2.9
引用产品: PC-9 细胞 , A549 [A-549] 细胞 , BEAS-2B 细胞 , DMEM高糖 培养基 , 特级胎牛血清
-
Budding uninhibited by benzimidazoles 1 overexpression is associated with poor prognosis and malignant phenotype: A promising therapeutic target for lung adenocarcinoma (2023-02-24)
作者:Rui Chen:1.Graduate School, Medical College of Nanchang University, Nanchang, China. ; 2.Jiangxi Key Laboratory of Translational Research for Cancer, Jiangxi Clinical Research Center for Cancer, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, China. ; Zhiping Wang:1.Fujian Medical University, Fuzhou, China. ; Tianzhu Lu:1.Jiangxi Key Laboratory of Translational Research for Cancer, Jiangxi Clinical Research Center for Cancer, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, China. ; Yuzhen Liu:1.Graduate School, Medical College of Nanchang University, Nanchang, China. ; 2.Jiangxi Key Laboratory of Translational Research for Cancer, Jiangxi Clinical Research Center for Cancer, Jiangxi Cancer Hospital, The Second Affiliated Hospital of Nanchang Medical College, Nanchang, China. ; Yulong Ji:1.Jiangxi Key Laboratory of Translational Research for Cancer, Jiangxi Clinical Research Center for Canc
期刊:Budding uninhibited by benzimidazoles 1 overexpression is associated with poor prognosis and malignant phenotype: A promising therapeutic target for lung adenocarcinoma
影响因子 :2.9
引用产品: MRC-5 细胞 , MRC-5细胞专用培养基 , NCI-H1299 细胞 , NCI-H1975 细胞 , A549 [A-549] 细胞 , NCI-H1650 细胞 , PC-9 细胞
-
Upregulation of NDUFAF2 in Lung Adenocarcinoma Is a Novel Independent Prognostic Biomarker (2023-01-17)
作者:Kang Zou:1.Department of Critical Care Medicine, Medical Center of Anesthesiology and Pain, The First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi Province 330006, China. ; 2.Department of Critical Care Medicine, The First Affiliated Hospital of Gannan Medical College, Ganzhou City, Jiangxi Province 341000, China. ; Pengxiang Gao:1.Department of Respiratory Medicine, The First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi Province 330006, China. ; Xinping Xu:1.Jiangxi Institute of Respiratory Diseases, The First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi Province 330006, China. ; 2.Jiangxi Clinical Research Center for Respiratory Diseases, The First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi Province 330006, China. ; Wei Zhang:1.Department of Respiratory Medicine, The First Affiliated Hospital of Nanchang University, Nanchang City, Jiangxi Province 330006, China. ; 2.Jiangxi Institute of Respi
期刊:Upregulation of NDUFAF2 in Lung Adenocarcinoma Is a Novel Independent Prognostic Biomarker
影响因子 :2.8
引用产品: PC-9 细胞 , NCI-H358 细胞 , A549 [A-549] 细胞 , HCC827 细胞 , NCI-H1299 细胞 , NCI-H1975 细胞 , BEAS-2B 细胞
-
Identification of a novel intermittent hypoxia-related prognostic lncRNA signature and the ceRNA of lncRNA GSEC/miR-873-3p/EGLN3 regulatory axis in lung adenocarcinoma (2023-10-10)
作者:Peijun Liu:1.Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, Hubei, China. ; Long Zhou:1.Department of Respiratory and Critical Care Medicine, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi Clinical College of Wuhan University, Enshi, Hubei, China. ; Hao Chen:1.Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, Hubei, China. ; Yang He:1.Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, Hubei, China. ; Guangcai Li:1.Department of Respiratory and Critical Care Medicine, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi Clinical College of Wuhan University, Enshi, Hubei, China. ; Ke Hu:1.Department of Respiratory and Critical Care Medicine, Renmin Hospital of Wuhan University, Wuhan, Hubei, China. ;
期刊:Identification of a novel intermittent hypoxia-related prognostic lncRNA signature and the ceRNA of lncRNA GSEC/miR-873-3p/EGLN3 regulatory axis in lung adenocarcinoma
影响因子 :2.7
引用产品: A549 [A-549] 细胞 , PC-9 细胞
-
Hsa_circ_0080608 Attenuates Lung Cancer Progression by Functioning as a Competitive Endogenous RNA to Regulate the miR-661/ADRA1A Pathway (2023-10-11)
作者:Chengbo Ren:1.Department of Radiotherapy, The First Affiliated Hospital of Hebei North University, Zhangjiakou, China. ; Ling Cui:1.Department of Radiotherapy, The First Affiliated Hospital of Hebei North University, Zhangjiakou, China. ; Ruibiao Li:1.Department of Radiotherapy, The First Affiliated Hospital of Hebei North University, Zhangjiakou, China. ; Xiao Song:1.Department of Radiotherapy, The First Affiliated Hospital of Hebei North University, Zhangjiakou, China. ; Jinqiu Li:1.Department of Radiotherapy, The First Affiliated Hospital of Hebei North University, Zhangjiakou, China. ; Qiang Xi:1.Department of Radiotherapy, The First Affiliated Hospital of Hebei North University, Zhangjiakou, China. ; Zhilin Zhang:1.Department of Radiotherapy, The First Affiliated Hospital of Hebei North University, Zhangjiakou, China. ; Lixia Zhao:1.Department of Internal Medicine Oncology, The First Affiliated Hospital of Hebei North University, Zhangjiakou, China. ;
期刊:Hsa_circ_0080608 Attenuates Lung Cancer Progression by Functioning as a Competitive Endogenous RNA to Regulate the miR-661/ADRA1A Pathway
影响因子 :2.2
引用产品: A549 [A-549] 细胞 , Calu-3 细胞 , NCI-H1975 细胞 , PC-9 细胞 , BEAS-2B 细胞 , RPMI-1640 培养基 , 特级胎牛血清 , DMEM高糖 培养基
-
Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on glutamine metabolism in lung adenocarcinoma (2022-08-11)
作者:Jichang Liu:1.Institute of Oncology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China. ; Hongchang Shen:1.Department of Oncology, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, China. ; Wenchao Gu:1.Department of Diagnostic and Interventional Radiology, University of Tsukuba, Ibaraki, Japan. ; 2.Department of Diagnostic Radiology and Nuclear Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan. ; Haotian Zheng:1.Institute of Oncology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China. ; Yadong Wang:1.Institute of Oncology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China. ; Guoyuan Ma:1.Institute of Oncology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China. ; 2.Department of Thoracic Surgery, Shandong Provincial Hospital, Cheeloo College of Medicine, S
期刊:Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on glutamine metabolism in lung adenocarcinoma
影响因子 :8.8
引用产品: PC-9 细胞 , A549 [A-549] 细胞 , THP-1 细胞
-
Tumor-suppressive E3 ubiquitin ligase CHIP inhibits the PBK/ERK axis to repress stem cell properties and radioresistance in non-small cell lung cancer (2022-11-27)
作者:Bo Tan:1.Department of Radiotherapy, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, 127 Dongming Road, Jinshui, Zhengzhou, 450008, Henan, China. zlyytanbo3069@zzu.edu.cn. ; Jingwei Zhang:1.Department of Radiotherapy, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, 127 Dongming Road, Jinshui, Zhengzhou, 450008, Henan, China. ; Wen Wang:1.Department of Radiotherapy, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, 127 Dongming Road, Jinshui, Zhengzhou, 450008, Henan, China. ; Haibo Ma:1.Department of Thoracic Surgery, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China. ; Yuanyuan Yang:1.Department of Radiotherapy, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, 127 Dongming Road, Jinshui, Zhengzhou, 450008, Henan, China. ;
期刊:Tumor-suppressive E3 ubiquitin ligase CHIP inhibits the PBK/ERK axis to repress stem cell properties and radioresistance in non-small cell lung cancer
DOI:10.1007/s10495-022-01789-y
影响因子 :5.6
引用产品: PC-9 细胞 , A549 [A-549] 细胞 , NCI-H1299 细胞 , NCI-H1975 细胞 , BEAS-2B 细胞 , RPMI-1640 培养基 , BEAS-2B细胞专用培养基 , EGF/Urogastrone/URG, Human, Recombinant , FGF-2/ bFGF/ FGF-b (Q65I, C96S, N111G), Human, Recombinant
-
Cyclin D1 mediated by the nuclear translocation of nuclear factor kappa B exerts an oncogenic role in lung cancer (2003-02-20)
作者:Xin Wang:1.Department of Respiratory and Critical Care Medicine, Second People's Hospital of Gansu Province & Northwest University for Nationality, Lanzhou, Gansu, China. ; Xiaoping Liu:1.Department of Respiratory and Critical Care Medicine, Second People's Hospital of Gansu Province & Northwest University for Nationality, Lanzhou, Gansu, China. ; Yanxia Yang:1.Department of Respiratory and Critical Care Medicine, Second People's Hospital of Gansu Province & Northwest University for Nationality, Lanzhou, Gansu, China. ; Daowen Yang:1.Department 1 of Lung Disease of TCM, China-Japan Friendship Hospital, Beijing, Chaoyang, China. ;
期刊:Cyclin D1 mediated by the nuclear translocation of nuclear factor kappa B exerts an oncogenic role in lung cancer
DOI:10.1080/21655979.2022.2043099
影响因子 :4.9
引用产品: PC-9 细胞
-
FOXP family DNA methylation correlates with immune infiltration and prognostic value in NSCLC (2022-09-09)
作者:Dong-Mei Hu:1.Shandong Key Laboratory of Infectious Respiratory Diseases, Department of Pulmonary and Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, China. ; 2.Laboratory of Basic Medical Sciences, Qilu Hospital of Shandong University, Jinan, China. ; Wen-Di Zhang:1.Shandong Key Laboratory of Infectious Respiratory Diseases, Department of Pulmonary and Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, China. ; 2.Laboratory of Basic Medical Sciences, Qilu Hospital of Shandong University, Jinan, China. ; Zhuang-E Shi:1.Shandong Key Laboratory of Infectious Respiratory Diseases, Department of Pulmonary and Critical Care Medicine, Qilu Hospital of Shandong University, Jinan, China. ; 2.Laboratory of Basic Medical Sciences, Qilu Hospital of Shandong University, Jinan, China. ; Meng-Yu Zhang:1.Shandong Key Laboratory of Infectious Respiratory Diseases, Department of Pulmonary and Critical Care Medicine, Qilu Hospital of Shandong University, Jinan,
期刊:FOXP family DNA methylation correlates with immune infiltration and prognostic value in NSCLC
影响因子 :4.8
引用产品: BEAS-2B 细胞 , A549 [A-549] 细胞 , NCI-H1299 细胞 , PC-9 细胞 , NCI-H226 [H226] 细胞
-
SLC7A5 is a lung adenocarcinoma-specific prognostic biomarker and participates in forming immunosuppressive tumor microenvironment (2022-10-02)
作者:Yong Liu:1.Institute of Oncology, Shandong Provincial Hospital, Shandong University, Jinan, 250021, Shandong, China. ; Guoyuan Ma:1.Department of Thoracic Surgery, Shandong Provincial Hospital, Shandong University, Jinan, 250021, Shandong, China. ; Jichang Liu:1.Institute of Oncology, Shandong Provincial Hospital, Shandong University, Jinan, 250021, Shandong, China. ; Haotian Zheng:1.Institute of Oncology, Shandong Provincial Hospital, Shandong University, Jinan, 250021, Shandong, China. ; Gemu Huang:1.Amoy Diagnostics Co., LTD., Xiamen, 361010, Fujian, China. ; Qingtao Song:1.Amoy Diagnostics Co., LTD., Xiamen, 361010, Fujian, China. ; Zhaofei Pang:1.Institute of Oncology, Shandong Provincial Hospital, Shandong University, Jinan, 250021, Shandong, China. ; 2.Institute of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China. ; 3.Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medic
期刊:SLC7A5 is a lung adenocarcinoma-specific prognostic biomarker and participates in forming immunosuppressive tumor microenvironment
DOI:10.1016/j.heliyon.2022.e10866
影响因子 :3.8
引用产品: A549 [A-549] 细胞 , HCC827 细胞 , NCI-H1975 细胞 , PC-9 细胞
-
High level of LncRNA MAPKAPK5-AS1 predicts poor prognosis and contributes to the malignant proliferation and EMT of non-small cell lung cancer via sponging miR-490-3p from HMGB2 (2022-11-29)
作者:Jidong Miao:1.Department of Oncology, Zigong Fourth People's Hospital, No.282, Dangui Street, Ziliujing District, Zigong City, 643000, Sichuan Province, People's Republic of China. ; Yang Gao:1.Department of Oncology, Zigong Fourth People's Hospital, No.282, Dangui Street, Ziliujing District, Zigong City, 643000, Sichuan Province, People's Republic of China. ; Wenqiang Guan:1.Department of Oncology, Zigong Fourth People's Hospital, No.282, Dangui Street, Ziliujing District, Zigong City, 643000, Sichuan Province, People's Republic of China. ; Xiaolin Yu:1.Department of Laboratory Medicine, Zigong Fourth People's Hospital, Zigong City, Sichuan Province, People's Republic of China. ; Yong Wang:1.Department of Pathology, Zigong Fourth People's Hospital, Zigong City, Sichuan Province, People's Republic of China. ; Ping Jiang:1.Department of Radiology, Zigong Fourth People's Hospital, Zigong City, Sichuan Province, People's Republic of China. ; Lili Yang:1.Department of Oncology, Zigon
期刊:High level of LncRNA MAPKAPK5-AS1 predicts poor prognosis and contributes to the malignant proliferation and EMT of non-small cell lung cancer via sponging miR-490-3p from HMGB2
DOI:10.1007/s13258-022-01339-5
影响因子 :2.2
引用产品: PC-9 细胞 , 青霉素-链霉素溶液 (双抗),100×
-
Exosomal Delivery of FTO Confers Gefitinib Resistance to Recipient Cells through ABCC10 Regulation in an m6A-dependent Manner (2002-01-20)
作者:Peng Xiao:1.Department of Thoracic Surgery, The Third Xiangya Hospital, Central South University, Changsha, P.R. China. ; Yu-Kang Liu:1.Department of Thoracic Surgery, The Second Xiangya Hospital, Central South University, Changsha, P.R. China. ; Wei Han:1.Department of Thoracic Surgery, The Second Xiangya Hospital, Central South University, Changsha, P.R. China. ; Yan Hu:1.Department of Thoracic Surgery, The Second Xiangya Hospital, Central South University, Changsha, P.R. China. ; Bo-You Zhang:1.Department of Thoracic Surgery, The Second Xiangya Hospital, Central South University, Changsha, P.R. China. ; Wen-Liang Liu:1.Department of Thoracic Surgery, The Second Xiangya Hospital, Central South University, Changsha, P.R. China. liuwenliang@csu.edu.cn. ;
期刊:Exosomal Delivery of FTO Confers Gefitinib Resistance to Recipient Cells through ABCC10 Regulation in an m6A-dependent Manner
DOI:10.1158/1541-7786.MCR-20-0541
影响因子 :5.2
引用产品: PC-9 细胞 , NCI-H1975 细胞
-
Cucurbitacin B enhances apoptosis in gefitinib resistant non‑small cell lung cancer by modulating the miR‑17‑5p/STAT3 axis (2008-01-20)
作者:Baodan Yu:1.Department of Laboratory Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, P.R. China. ; Lixia Zheng:1.Department of Hematology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, P.R. China. ; Huiqin Tang:1.Department of Laboratory Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, P.R. China. ; Weixin Wang:1.Department of Laboratory Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, P.R. China. ; Yongping Lin:1.Department of Laboratory Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, P.R. China. ;
期刊:Cucurbitacin B enhances apoptosis in gefitinib resistant non‑small cell lung cancer by modulating the miR‑17‑5p/STAT3 axis
影响因子 :3.4
引用产品: PC-9 细胞
-
Calponin 3 suppresses proliferation, migration and invasion of non‑small cell lung cancer cells (2007-01-20)
作者:Chenglin Yang:1.Traditional Chinese Medicine Department, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong 510632, P.R. China. ; Shiping Zhu:1.Traditional Chinese Medicine Department, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong 510632, P.R. China. ; Weifeng Feng:1.Traditional Chinese Medicine Department, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong 510632, P.R. China. ; Xuexin Chen:1.Department of Respiratory and Critical Care Medicine, The General Hospital of Yima Coal Industry Group Co. Ltd., Yima, Henan 472300, P.R. China. ;
期刊:Calponin 3 suppresses proliferation, migration and invasion of non‑small cell lung cancer cells
影响因子 :2.9
引用产品: PC-9 细胞 , NCI-H1975 细胞 , NCI-H520 细胞
-
UTMD-mediated delivery of miR-21-5p inhibitor suppresses the development of lung cancer (2012-01-20)
作者:Xiaoyu Zhou:1.Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Jinan University, 613 W. Huangpu Avenue, Guangzhou City, Guangdong Province, 510630, China; Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Bengbu Medical College, 287 Changhuai Road, Longzihu District, Bengbu City, Anhui Province, 233000, China. ; Haitao Liu:1.Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Bengbu Medical College, 287 Changhuai Road, Longzihu District, Bengbu City, Anhui Province, 233000, China. ; Yingying Pang:1.Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Bengbu Medical College, 287 Changhuai Road, Longzihu District, Bengbu City, Anhui Province, 233000, China. ; Muqun Wang:1.Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Bengbu Medical College, 287 Changhuai Road, Longzihu District, Bengbu City, Anhui Province, 23300
期刊:UTMD-mediated delivery of miR-21-5p inhibitor suppresses the development of lung cancer
DOI:10.1016/j.tice.2021.101719
影响因子 :2.6
-
LncRNA CCAT2 promotes tumorigenesis by over-expressed Pokemon in non-small cell lung cancer (2001-07-20)
作者:Zhihong Zhao:1.Department of Thoracic Surgery, The First Affiliated Hospital of Harbin Medical University, China. Electronic address: zhihongzhao123@126.com. ; Ju Wang:1.Department of Thoracic Surgery, The First Affiliated Hospital of Harbin Medical University, China. ; Shengfa Wang:1.Department of Thoracic Surgery, The First Affiliated Hospital of Harbin Medical University, China. ; Hao Chang:1.Department of Thoracic Surgery, The First Affiliated Hospital of Harbin Medical University, China. ; Tiewa Zhang:1.Department of Thoracic Surgery, The First Affiliated Hospital of Harbin Medical University, China. ; Junfeng Qu:1.Department of Thoracic Surgery, The First Affiliated Hospital of Harbin Medical University, China. ;
期刊:LncRNA CCAT2 promotes tumorigenesis by over-expressed Pokemon in non-small cell lung cancer
DOI:10.1016/j.biopha.2016.12.122
影响因子 :7.5
引用产品: PC-9 细胞 , NCI-H358 细胞 , NCI-H1975 细胞 , HBE135-E6E7 细胞
FAQs
Q:{{item.question}}
A:
产品资料
识别码示意图